Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoTwo participant cohorts were evaluated, including those previously treated with BCMA-targeted...
Study shows bursts of exercise may boost antibody therapy for blood cancer
Local 12 Cincinnati· 7 days agoStaying active during cancer treatment could actually boost how well at least one type of treatment works. A new study showed that moderate to intense bursts of exercise may ...
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Medscape· 3 days agoAnti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a...
What causes long COVID? Case builds for rogue antibodies
Nature· 4 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
New platform streamlines epitope comparison in antibody research
Medical Xpress· 7 days agoMonoclonal antibodies are crucial therapeutics due to their high specificity and binding affinity...
New Research: Convenient At-Home Test Identifies A | Newswise
Newswise· 5 days agoDuring the COVID-19 pandemic, at-home antigen tests became widely accepted for detecting infection. In a new joint study by the George Washington University, the University ...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 2 hours agoNovavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval...
Scientists engineer human antibodies that could neutralize black widow toxin
Medical Xpress· 5 days agoThere are various types of widow spiders, including black, red, and brown varieties in North and...
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 6 days agoAfter Lilly provided additional information from a late-stage trial, the agency convened its...